claudin 18.2 targeted therapy

Latest Post

Biogen Q3 2026 Results: Revenue Rises 11% as Company Raises Earnings Guidance Nucelion and Pandorum Partner on ₹17 Crore Eye-Therapy Research Programmes Vera Health Raises $28.5 Million to Expand Its Clinical AI Search Platform Hundreds of UK GP Websites Hit by Healthcare Technology Provider Collapse India Revises Prices of 543 Cancer-Medicine Brands: New Rates From November 9

AstraZeneca Stomach Cancer Drug Trial: 53% Lower Death Risk, But PFS Misses

October 26, 2026 Simone Lamb

The AstraZeneca stomach cancer drug trial showed a 53% lower risk of death in later-line patients, but progression-free survival missed significance.

You missed

Biogen Q3 2026 Results: Revenue Rises 11% as Company Raises Earnings Guidance

October 29, 2026 Simone Lamb

Nucelion and Pandorum Partner on ₹17 Crore Eye-Therapy Research Programmes

October 29, 2026 Simone Lamb

Vera Health Raises $28.5 Million to Expand Its Clinical AI Search Platform

October 29, 2026 Simone Lamb

Hundreds of UK GP Websites Hit by Healthcare Technology Provider Collapse

October 29, 2026 Simone Lamb